Otelixizumab (Anti-CD3)
Otelixizumab (Anti-CD3) is a human monoclonal antibody targeting CD3. It can be used for the research of type 1 diabetes. MW :145.14 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3004 |
| Sku # | A3004-1mg*5 |
| Pricing | 1mg*5, $970.00 |